Markets
Stocks
Mutual Funds & ETFs
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
BioSpecifics Technologies Corp. (NQ: BSTC)
21.78 USD  +0.31 (+1.44%)
Official Closing Price  /  Updated: 5:20 PM EST, Dec 13, 2013  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 22,023
Open 21.47
Bid (Size) 21.78 (100)
Ask (Size) 21.88 (100)
Prev. Close 21.47
Today's Range 21.47 - 22.09
52wk Range 13.50 - 23.75
Shares Outstanding 6,337,968
Dividend Yield N/A
Performance
YTD
+43.29%
+43.29%
1 Month
+3.22%
+3.22%
3 Month
+24.10%
+24.10%
6 Month
+37.67%
+37.67%
1 Year
+59.79%
+59.79%
Top News
More News
BioSpecifics Technologies Corp. Announces Initiation of Phase 2b Trial of CCH for Treatment of Frozen Shoulder Syndrome
Today 8:42 EST
from PR Newswire
BioSpecifics Technologies Corp. Announces Board Authorization of up to $2 Million Stock Repurchase Program
December 12, 2013
from PR Newswire
More News
Read More
BioSpecifics Technologies Corp. Announces FDA Approval of XIAFLEX® for the Treatment of Peyronie's Disease
December 06, 2013
from PR Newswire
BioSpecifics Technologies Corp. Announces Positive Top-line Data from XIAFLEX® MULTICORD Phase IIIb Study
November 18, 2013
from PR Newswire
BioSpecifics Technologies Corp. Reports Third Quarter 2013 Financial Results
November 12, 2013
from PR Newswire
BioSpecifics Technologies Corp. to Host Conference Call to Report Third Quarter 2013 Financial Results on Tuesday, November 12, 2013
November 05, 2013
from PR Newswire
BioSpecifics Technologies Corp. Announces Initiation of Phase 2a Study of XIAFLEX for Treatment of Cellulite
October 23, 2013
from PR Newswire
BioSpecifics Technologies Initiates Phase 2b Trial of CCH for Treatment of Frozen Shoulder Syndrome
Today 8:44 EST
category Management , Benzinga , Global , and 5 more.
from Latest Articles from Benzinga.com
BioSpecifics Technologies Corp. Announces Data from Multiple Studies of XIAFLEX for Treatment of Dupuytren's Contracture Presented at American Society for Surgery of the Hand 2013
October 07, 2013
from PR Newswire
BioSpecifics Technologies (BSTC) up on new tests
Today 11:03 EST
from BAYSTREET RSS FEED
BioSpecifics Technologies Corp. to Present at the Aegis Capital 2013 Healthcare Conference
September 19, 2013
from PR Newswire
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here